Louisiana State Employees Retirement System Takes $582,000 Position in Healthpeak Properties, Inc. $DOC

Louisiana State Employees Retirement System purchased a new stake in Healthpeak Properties, Inc. (NYSE:DOC) in the first quarter, Holdings Channel reports. The firm purchased 35,400 shares of the real estate investment trust’s stock, valued at approximately $582,000.

Other hedge funds and other institutional investors also recently bought and sold shares of the company. Norges Bank purchased a new stake in shares of Healthpeak Properties in the 4th quarter worth $153,550,000. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC raised its holdings in shares of Healthpeak Properties by 694.6% in the third quarter. UBS AM A Distinct Business Unit of UBS Asset Management Americas LLC now owns 8,016,692 shares of the real estate investment trust’s stock valued at $153,520,000 after acquiring an additional 7,007,777 shares in the last quarter. Fuller & Thaler Asset Management Inc. raised its holdings in shares of Healthpeak Properties by 19.2% in the fourth quarter. Fuller & Thaler Asset Management Inc. now owns 29,648,260 shares of the real estate investment trust’s stock valued at $476,744,000 after acquiring an additional 4,776,056 shares in the last quarter. Bank of New York Mellon Corp lifted its stake in Healthpeak Properties by 42.7% in the fourth quarter. Bank of New York Mellon Corp now owns 9,641,231 shares of the real estate investment trust’s stock worth $155,031,000 after acquiring an additional 2,887,084 shares during the period. Finally, Millennium Management LLC grew its holdings in Healthpeak Properties by 235.3% during the 4th quarter. Millennium Management LLC now owns 3,512,223 shares of the real estate investment trust’s stock worth $56,477,000 after acquiring an additional 2,464,612 shares in the last quarter. Institutional investors own 93.57% of the company’s stock.

Insiders Place Their Bets

In other Healthpeak Properties news, insider Scott R. Bohn sold 10,989 shares of Healthpeak Properties stock in a transaction on Tuesday, May 12th. The shares were sold at an average price of $19.45, for a total value of $213,736.05. Following the transaction, the insider directly owned 7,636 shares of the company’s stock, valued at approximately $148,520.20. The trade was a 59.00% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. 0.23% of the stock is currently owned by company insiders.

Healthpeak Properties Stock Performance

Shares of Healthpeak Properties stock opened at $21.95 on Wednesday. The company has a market capitalization of $15.13 billion, a PE ratio of 68.60, a P/E/G ratio of 3.39 and a beta of 1.02. The company has a debt-to-equity ratio of 1.15, a quick ratio of 2.96 and a current ratio of 2.96. The company has a 50-day simple moving average of $19.76 and a two-hundred day simple moving average of $17.93. Healthpeak Properties, Inc. has a one year low of $15.70 and a one year high of $22.13.

Healthpeak Properties (NYSE:DOC) last issued its quarterly earnings data on Tuesday, May 5th. The real estate investment trust reported $0.45 earnings per share (EPS) for the quarter, topping analysts’ consensus estimates of $0.43 by $0.02. The firm had revenue of $752.95 million for the quarter, compared to the consensus estimate of $694.59 million. Healthpeak Properties had a net margin of 7.73% and a return on equity of 2.61%. The company’s quarterly revenue was up 7.1% compared to the same quarter last year. During the same quarter in the previous year, the firm earned $0.46 EPS. Healthpeak Properties has set its FY 2026 guidance at 1.710-1.750 EPS. Research analysts expect that Healthpeak Properties, Inc. will post 1.75 EPS for the current fiscal year.

Wall Street Analysts Forecast Growth

A number of research analysts have commented on the stock. Barclays initiated coverage on shares of Healthpeak Properties in a research report on Tuesday. They set an “equal weight” rating and a $23.00 target price on the stock. Raymond James Financial began coverage on shares of Healthpeak Properties in a research note on Wednesday, June 17th. They set a “market perform” rating on the stock. Wells Fargo & Company lifted their price objective on shares of Healthpeak Properties from $18.00 to $20.00 and gave the company an “equal weight” rating in a report on Monday, June 1st. Royal Bank Of Canada boosted their price objective on shares of Healthpeak Properties from $20.00 to $21.00 and gave the stock an “outperform” rating in a research note on Thursday, May 14th. Finally, Robert W. Baird upped their target price on Healthpeak Properties from $19.00 to $21.00 and gave the stock an “outperform” rating in a report on Wednesday, May 13th. Four analysts have rated the stock with a Buy rating and fifteen have given a Hold rating to the company’s stock. According to data from MarketBeat.com, the company presently has a consensus rating of “Hold” and a consensus target price of $20.35.

Healthpeak Properties Profile

Healthpeak Properties, Inc is a real estate investment trust (REIT) specializing in healthcare-related real estate. Headquartered in Irvine, California, the company owns, develops and acquires a diversified portfolio of properties that cater to the evolving needs of the healthcare industry. Its investments span life science research facilities, medical office buildings and senior housing communities, positioning Healthpeak as a key provider of specialized real estate assets.

Within its life science segment, Healthpeak develops and leases laboratory and research space to biotechnology, pharmaceutical and other life science companies.